1. 92001 Maxim HIV-1 Limiting Antigen Avidity (LAg-Avidity) EIA Kit, 192 Tests
    The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing 
    recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG 
    populations with higher proportions of lower avidity IgG than those with long-term infections which typically exhibit higher proportions of 
    higher avidity IgG. The Maxim HIV-1 LAg-Avidity EIA uses US CDC developed technology and is designed for surveillance purposes such as 
    estimating HIV-1 incidence in a population, monitoring and evaluating HIV intervention programs, and recognizing those high-incidence 
    populations so that prevention research, vaccine trials, and resources are most appropriately utilized. This product is for research use only 
  2. 92002 Maxim Swift HIV Recent Infection Assay (RIA), 20 Tests
    The Maxim SwiftTM HIV Recent Infection Assay (RIA) is a single use qualitative immunoassay to detect the circulating antibodies to Human 
    Immunodeficiency Virus Type 1 (HIV-1), Type 2 (HIV-2) and distinguish between recent and long-term infection in HIV-1. The assay is a point of 
    care (POC) test intended for use with blood or serum/ plasma specimens. The Maxim SwiftTM HIV RIA uses US CDC developed materials and 
    is designed for surveillance purposes such as estimating HIV-1 incidence in a population, monitoring and evaluating HIV intervention programs, 
    and recognizing those high-incidence populations so that prevention research, vaccine trials, and resources are most appropriately utilized. 
    This product is for research use only and is not intended for use in diagnostic procedures.

  3. 92002-C Maxim Swift HIV Recent Infection Assay (RIA) Kit Controls, 45 Tests
    The Maxim SwiftTM HIV Recent Infection Assay (RIA) Kit Controls are quality control reagents for use only with the Maxim SwiftTM HIV Recent 
    Infection Assay (RIA) (P/N 92002). They are used to verify that the test kit reagents are working and that the test is performed correctly. The 
    Maxim SwiftTM HIV RIA uses US CDC developed materials and is designed for surveillance purposes such as estimating HIV-1 incidence in a 
    population, monitoring and evaluating HIV intervention programs, and recognizing those high-incidence populations so that prevention 
    research, vaccine trials, and resources are most appropriately utilized. Controls should be stored at 4-8°C for long-term storage (12 months) 
    or at -20°C (24 months). This product is for research use only and is not intended for use in diagnostic procedures.

  4. 92003 Maxim HIV-1 Limiting Antigen Avidity (LAg-Avidity) DBS EIA Kit, 192 Tests
    The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing 
    recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG 
    populations with higher proportions of lower avidity IgG than those with long-term infections which typically exhibit higher proportions of 
    higher avidity IgG. The Maxim HIV-1 LAg-Avidity EIA uses US CDC developed technology and is designed for surveillance purposes such as 
    estimating HIV-1 incidence in a population, monitoring and evaluating HIV intervention programs, and recognizing those high-incidence 
    populations so that prevention research, vaccine trials, and resources are most appropriately utilized. This product is for research use only 
    and is not intended for use in diagnostic procedures.

  5. 98002 Cambridge Biotech HIV-1 Serum Western Blot, 27 Tests
    Maxim's Cambridge biotech HIV-1 Serum Western Blot Kit is an FDA Approved in-vitro qualitative assay for the detection and identification of 
    antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) contained in human serum or plasma. It is intended for use with persons of 
    unknown risks as an additional specific test on human serum or plasma specimens found to be repeatedly reactive using a screening 
    procedure, such as an Enzyme-Linked Immunosorbent Assay (ELISA).


  6. 98078 Cambridge Biotech HIV-1 Urine Western Blot, 27 Tests
    Maxim's Cambridge Biotech HIV-1 Urine Western Blot Kit is an FDA approved in-vitro qualitative assay for the detection and identification of 
    antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) contained in human urine. This more specific assay is used as a supplemental test 
    with urine specimens that tested repeatedly reactive using a screening procedure (e.g. FDA Approved Maxim HIV-1 Urine EIA).


  7. 700000 Maxim HIV-1 Urine EIA Kit, 480 Tests
    Maxim's FDA Approved HIV-1 Urine EIA test is an enzyme immunoassay for the in-vitro detection of antibodies to Human Immunodeficiency 
    Virus Type 1 (HIV-1) in urine. The test is intended for use in professional laboratory settings as an aid in clinical diagnosis of HIV infection. 
    Before a determination of HIV-1 status can be made, specimens that are repeatedly reactive using this test should be further tested using 
    Maxim's additional, more specific FDA approved Cambridge Biotech Western Blot Kit

Internal Reference: YF-PA26408